Star Combo Pharma Limited (ASX:S66)

Star Combo Pharma Revenue

In the fiscal year ending June 30, 2025, Star Combo Pharma had annual revenue of 27.81M AUD with 6.89% growth. Star Combo Pharma had revenue of 11.90M in the half year ending June 30, 2025, a decrease of -9.17%.

• Revenue: 27.81M
• Revenue Growth: +6.89%
• P/S Ratio: 1.09
• Revenue / Employee: 927.05K
• Employees: 30
• Market Cap: 30.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	27.81M	1.79M	6.89%
Jun 30, 2024	26.02M	1.32M	5.34%
Jun 30, 2023	24.70M	1.74M	7.57%
Jun 30, 2022	22.96M	-4.01M	-14.86%
Jun 30, 2021	26.97M	-12.11M	-31.00%